By Springer Healthcare IME Next-generation CAR-T cell therapy for high-risk LBCL and R/R DLBCL ...more
By Kamran Ahmad Integrating tumor microenvironment biology with clinical impact: Evolving understanding of therapeutic approaches for MF‑CTCL ...more
By Kamran Ahmad Biomarker-Positive Disease: A Personalized Approach to Selecting Targeted Therapies in Lung Cancer and Beyond ...more
